Regeneron (REGN) is a publicly traded Healthcare sector company. As of May 20, 2026, REGN trades at $643.47 with a market cap of $66.02B and a P/E ratio of 15.17. REGN moved +2.94% today. Year to date, REGN is -14.87%; over the trailing twelve months it is +5.69%. Its 52-week range spans $476.49 to $1,070.00. Analyst consensus is strong buy with an average price target of $884.89. Rallies surfaces REGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading REGN stock inside the company?
Recent REGN insider activity includes RYAN ARTHUR F sold 1, RYAN ARTHUR F sold 3, RYAN ARTHUR F sold 8, RYAN ARTHUR F sold 8, and RYAN ARTHUR F sold 14. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Recent REGN insider activity includes RYAN ARTHUR F sold 1, RYAN ARTHUR F sold 3, RYAN ARTHUR F sold 8, RYAN ARTHUR F sold 8, and RYAN ARTHUR F sold 14. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for REGN?
Yes. Rallies tracks REGN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is REGN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for REGN. It does not provide personalized investment advice.
